Joint pharmacometrics modeling of antimicrobial exposure, biomarkers, and clinical outcome assessments to improve the in silico exploration of dose optimization strategies in critically ill patients
A Pharmacometrics Approach to Improve Dose Individualisation Methods of Biologicals in Patients with Chronic Inflammatory Diseases
A Pharmacometrics Approach to Guide Dose Optimization of anti-infective drugs in special patient populations
Pharmacometric models for improved therapeutic drug monitoring of ceftriaxone, posaconazole and infliximab
Dose optimisation of antimicrobial agents in veterinary medicine using pharmacometrics to improve one health antimicrobial sustainability : the case of enrofloxacin and avian pathogenic Escherichia coli infections in broiler chickens
Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates